Navigation Links
Basis for Nerve fiber Damage in Multiple Sclerosis Discovered

antly, these are the first antibodies to be identified with axon activity, which is a new area researchers are exploring in the pathology of MS." MS is a chronic central nervous system disease that can cause blurred vision, poor coordination, slurred speech, numbness, acute fatigue and, in its most extreme form, blindness and paralysis. Some 400,000 Americans have this disease. Its causes are unknown, and symptoms are unpredictable and vary greatly in severity. Much MS research is focused on an autoimmune process in which T-cells attack and damage myelin, the fatty insulating tissue of axons. These T-cells do not attack axons themselves; the process of demyelination interrupts electrical impulses that run through these nerve fibers, thus causing MS symptoms. Demyelination has been considered the central feature of MS.

Recently, however, Qin has been among a group of researchers who have discovered that B-cells too are involved with the autoimmune response to MS. Instead of targeting myelin, these B-cells attack axons directly. Axons are the long, slender fibers of a neuron that serve as the primary transmission lines of the nervous system, and as bundles they help make up nerves.

Research at UCI and elsewhere has shown that myelin grows back if the T-cell autoimmune response is turned off, and drugs exist or are in development to block demyelination. Axons, in turn, repair very slowly, which implies that B-cell attacks on axons may have a significant impact on the chronic central nervous system damage caused by MS. "Since this area of research is in its early stage, it’s important to understand the process by which these B-cell responses happen," Qin said. "Hopefully, by identifying these two crucial enzymes, it will lead to a greater understanding of MS and lead to more effective treatments for people who live with this disease."

Johanna Kolln, Hui-Min Ren, Reng-Rong Da, Yiping Zhang, Dr. Michael Olek, Dr. Neal Hermanowicz, Lutz
'"/>




Page: 1 2 3

Related medicine news :

1. Genetics Might BE The Basis For Chronic Fatigue Syndrome
2. Molecular Basis Of ALS Found
3. Biological Basis for Homosexuality
4. Biological Basis Behind a Couch Potato
5. Researchers Develop Basis For Experimental Melanoma Treatment
6. Researchers Investigate Molecular Basis of Memory
7. Epilepsy Drug Helps Diabetic Nerve Damage
8. World’s First Nerve Stem Cells Produced
9. Children With Epilepsy Can Be Treated With Nerve Stimulation
10. FDA Approved Nerve-Stimulation Therapy Now Available In New York
11. Doctors Finish Mother-To-Son Nerve Surgery
Post Your Comments:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...In the first publicised high-level meeting, Prime ...nt incidences of vector borne diseases// including...an early warning system on epidemic outbreaks. Acc...ople have died this year due to spread of dengue a...
...Tuberculosis which was the biggest killer disease ...ith a leap of over 10% from 2004 to 2005. //Th num..., but this has been the single largest leap , caus...h agencies. The disease which killed several famou...
...Doctors have cautioned against the use of party pi...he Medical Association has warned that party pills...hypothermia. The Chairman of the association, Ross...finding on the potentially lethal side effects of ...
...According to a recent study in the U.S, divorce af...d Lorenz, who co-authored the report at Iowa State... Research, said: “What we found was that the act o...diate effects on (physical) health, but it did hav...
Other Medicine News:Health News:TB Returns , Sharp Rise In Cases In UK 2
(Date:8/18/2008)...nical Trials Phase of Test Development Program, O...l/ -- Beckman,Coulter, Inc. (NYSE: BEC ) announce... U.S. royalty obligation to Nephromics LLC, a Ches...health. The license is for tests,related to the de...mpsia, a,leading cause of maternal death. In addit...
(Date:8/18/2008)...g. 18 /- Micromet, Inc.,(Na...ing novel, proprietary,antibodies for the treatmen... will host a webcast and conference call this morn...n Time (4:00 p.m. Central European,Time) to discus... Journal,SCIENCE on August 15, 2008., To access t...
(Date:8/14/2008)...5 /- AstraZeneca (NYSE: AZ...with the National Cancer,Centre Singapore (NCCS) a...op anti-cancer compounds. The collaboration, which...U) that was signed today, aims to further,build As...and ultimately,speed up access to new medicines of...
(Date:8/14/2008)...ng antibody (BiTE) showing clinical benefit in can...cells to recognize and attack ...Newswire-FirstCall/ -- Micromet, Inc.,(Nasdaq: MI..., proprietary,antibodies for the treatment of canc...nounced publication of a Phase 1 clinical study(1)...
Breaking Medicine Technology:Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 2Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6Barr Confirms Patent Challenge of Sensipar 28R 29 Tablets 30mg 60mg and 90mg 6786 1Barr Confirms Patent Challenge of Sensipar 28R 29 Tablets 30mg 60mg and 90mg 6786 2Barr Confirms Patent Challenge of Sensipar 28R 29 Tablets 30mg 60mg and 90mg 6786 3ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti HIV Topical Microbicide 2730 1ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti HIV Topical Microbicide 2730 2New therapy for HIV treatment 24494 1New therapy for HIV treatment 24494 2W M Keck Foundation grant funds reproductive science research 4237 1W M Keck Foundation grant funds reproductive science research 4237 2W M Keck Foundation grant funds reproductive science research 4237 3
...r 26, 2007 - Inovio Biomedical Corp.,(AMEX:INO), w... and,a novel solid tumor ablation therapy, announc...d a scientific paper prepared by,Inovio,s developm...uman primate study of an investigational DNA vacci... electroporation technology.,The paper, titled "Ef...
... NCD, MKC-1, and ENMD-1198,Highlighted at Oncology...26, 2007 /PRNewswire-FirstCall/ --,EntreMed, Inc.,...g,therapeutics for the treatment of cancer and inf...on of comparative mechanism of action,data for its...C-1,and ENMD-1198. These data were presented by Dr...
Other Medicine Technology:Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 2Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 3Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 4EntreMed Presents Mechanism Data for Its Three Lead Oncology,Compounds 2EntreMed Presents Mechanism Data for Its Three Lead Oncology,Compounds 3EntreMed Presents Mechanism Data for Its Three Lead Oncology,Compounds 4
...n Through A 1.0mm Incision., ,Special Direct A...Ergonomics., ,Curved Shafts For A More Comfort...b-Incisional Flap Purchase., ,Protective Cap S...n., ,Reusable, Autoclaveable, Guaranteed For L...
The blades are actually bent to form a concave posterior surface. The result is a blade which better conforms to incising a globe at a non-perpendicular angle. The resulting incision is more pristine
...Design With Spreading Spatula Tips That Mimic Corn...g & Lifting Of Corneal Flaps Created With The Intr...ips Of The Forceps Are Designed To Facilitate Acce...d, The Cross-Action Forceps Design Allows The Surg...
...ut Foldable Silicone Lenses Through A Smaller Inci...en High Diopter Silicone Lenses With Ease With One...ertion Through A 2.6mm Phaco Incision For Explanta...ay Surgical Evaluation Without Obligation, & A Com...
Medicine Products: